Now
available

The first and only FDA-approved targeted treatment for people with relapsed or refractory FLT3m+ AML

Who should not take XOSPATA?

Do not take XOSPATA if you are allergic to gilteritinib or any of the ingredients in XOSPATA.

AML=acute myeloid leukemia; FDA=Food and Drug Administration;
FLT3=FMS-like tyrosine kinase 3; m+=mutation-positive.

testing